When malignant tumour cells affect the testicle, we talk about cancer of the testicle.
Testicular cancer is the most frequent neoplasm in young men, with an incidence just under two annual cases per 100,000 inhabitants.
Among the risk factors for the development of cancer of the testis is cryptorchidism (testicle undescended to scrotum at birth) and some chromosomal abnormalities (Klinefelter syndrome).
It usually manifest as a painless mass rooted in the testicle which requires its removal in a simple surgical act, which is sufficient as the only therapeutic act in some initial stages. Generally, testicular cancer has an excellent prognosis even in advanced states. It often requires treatment with chemotherapy and exceptionally with radiation therapy. Occasionally, it is necessary to remove abdominal lymph nodes (retroperitoneal lymphadenectomy), before or, more often, after chemotherapy treatment. The retroperitoneal residual mass surgery is complex and it is recommended that it be performed in specialized reference centres.
In this regard, the Department of Urology of the IVO has ample experience and has been a pioneer in our country in surgery with conservation of the nerves responsible for ejaculation and in the laparoscopic surgery approach, which can be done in selected cases.
Each case is evaluated individually by the Tumour Committee, since there is a broad range of cell lineages and stages of the disease that necessitate an individualized therapeutic approach and monitoring.
This type of cancer can present consequences in the field of fertility, sexuality and hormonal deficits which are also broached by an andrologist.